Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Longevity Predicted by High Naive White Cell Counts

By Labmedica staff writers
Posted on 09 Jul 2008
Naive white blood cell counts have been proposed as a means to predict longevity and even lead to a way for everyone to live longer.

B-cells are vital components of the immune system, producing antibodies to combat foreign invaders, such as bacteria. More...
Unlike mature B-cells, which are primed to attack foes the body has seen before, naive B-cells are ready and waiting to attack microbes not previously encountered. Therefore, the more naive B-cells present the longer someone is likely to be able to keep fighting off new infections, which might prolong life.

Sonya Vasto Ph.D. and her colleagues at the University of Palermo (Italy) took samples of white blood cells from 45 men and women aged between 75 and 90, who all had parents born between 1900 and 1908. They compared the numbers of naïve blood calls from those who had one parent who had reached 100 with those whose parents had died before reaching the average life expectancy for Italians (67 for men and 72 for women).

The two groups differed in the number of naive B-cells, a type of white blood cell that their blood contained. Our main finding was the increase in naive B-cells in individuals who had centenarian parents, said Dr. Vasto, who presented the results at a conference on aging organized by the Methuselah Foundation (Lorton, VA, USA). The conference took place in Los Angeles (CA, USA) from June 27-29, 2008.

Dr. Vasco said, "If people discover they have fewer naive B-cells, they might take extra steps to forestall infections.”


Related Links:
University of Palermo
Methuselah Foundation

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.